Medium-chain triglycerides induce alterations in carnitine metabolism.

Area of Science:

• Biochemistry
• Human Physiology
• Nutritional Science

Background:

• Medium-chain triglycerides (MCTs) are often presumed to be metabolized independently of carnitine.
• Carnitine plays a crucial role in fatty acid metabolism, particularly in transporting long-chain fatty acids into mitochondria for oxidation.

Purpose of the Study:

• To investigate the effects of intravenous medium-chain triglycerides (MCTs) on plasma carnitine derivatives and beta-hydroxybutyrate concentrations.
• To determine if MCT metabolism is indeed independent of carnitine, challenging existing assumptions.

Main Methods:

• Four healthy adult males received infusions of glucose and amino acids.
• Lipid emulsions containing either long-chain triglycerides (LCTs) or a 50:50 mixture of MCTs and LCTs were infused for 5.5 hours.
• Plasma concentrations of free carnitine, acylcarnitines, and beta-hydroxybutyrate were measured.

Main Results:

• Infusion of the MCT/LCT mixture significantly reduced free carnitine levels compared to LCT-only infusion.
• Plasma concentrations of short-chain acylcarnitine and beta-hydroxybutyrate were significantly higher with the MCT/LCT mixture.
• These findings indicate that MCTs are not metabolized independently of carnitine.

Conclusions:

• Intravenous medium-chain triglycerides (MCTs) interact with carnitine metabolism.
• Carnitine may be essential for processing acyl and acetyl groups derived from MCTs, aiding mitochondrial function.
• MCTs may facilitate an interorgan energy cycle by producing metabolites usable by various tissues.